| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034086881 |
| P356 | DOI | 10.1007/S11010-007-9503-9 |
| P698 | PubMed publication ID | 17530187 |
| P2093 | author name string | Jie Gao | |
| Xi Jin | |||
| Qian Chen | |||
| Zhiqin Wang | |||
| Di Yang | |||
| Zongcan Zhou | |||
| Juanling Fu | |||
| Xilong Xiao | |||
| Yitao Qi | |||
| P2860 | cites work | Mutations in the p53 gene in primary human breast cancers | Q68321480 |
| Wild-type human p53 activates the human epidermal growth factor receptor promoter | Q72351836 | ||
| NMR spectroscopy reveals the solution dimerization interface of p53 core domains bound to their consensus DNA | Q74631439 | ||
| Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells | Q79787890 | ||
| The effects of a mutant p53 protein on the proliferation and differentiation of PC12 rat phaeochromocytoma cells | Q79830553 | ||
| Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation | Q24301892 | ||
| Cytoplasmic p53 polypeptide is associated with ribosomes | Q24646226 | ||
| p53 inhibits RNA polymerase III-directed transcription in a promoter-dependent manner | Q24647526 | ||
| Surfing the p53 network | Q28032484 | ||
| Definition of a consensus binding site for p53 | Q28207794 | ||
| Oncogenic forms of p53 inhibit p53-regulated gene expression | Q28251120 | ||
| Identification of p53 as a sequence-specific DNA-binding protein | Q28282745 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age | Q29618409 | ||
| p53: death star | Q34103258 | ||
| Regulation of cyclin E transcription by E2Fs and retinoblastoma protein | Q34382483 | ||
| The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth | Q34402080 | ||
| Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells | Q34411420 | ||
| p53 function and dysfunction | Q35721291 | ||
| p53 mutation heterogeneity in cancer | Q36113160 | ||
| The p53 tumour suppressor gene | Q37751892 | ||
| Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1. | Q38319170 | ||
| DNA binding specificity of proteins derived from alternatively spliced mouse p53 mRNAs | Q38347516 | ||
| Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA. | Q38508706 | ||
| Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. | Q40265316 | ||
| Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells | Q40266928 | ||
| Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells | Q40281014 | ||
| Modulation of gene expression by tumor-derived p53 mutants | Q40502644 | ||
| A transcriptionally active DNA-binding site for human p53 protein complexes | Q40655196 | ||
| A novel p53 mutant retained functional activity in lung carcinomas. | Q40679879 | ||
| Synergistic action of Drosophila cyclins A and B during the G2-M transition | Q40871675 | ||
| Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes. | Q41073633 | ||
| A codon 248 p53 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisense p53. | Q41527846 | ||
| p53 is covalently linked to 5.8S rRNA. | Q41595909 | ||
| Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. | Q41643433 | ||
| p53 is a general repressor of RNA polymerase III transcription | Q42645736 | ||
| The p53 codon 249 mutant--derived from human functional adrenal tumors--can modify the cell shape of normal adrenocortical transfected cells | Q43670487 | ||
| Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication | Q44703400 | ||
| Mutant p53 gain of function: the NF-Y connection. | Q53600645 | ||
| Wild-type p53 activates transcription in vitro | Q59054260 | ||
| Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas | Q59317430 | ||
| Mutant p53 proteins bind DNA abnormally in vitro | Q67912813 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 219-226 | |
| P577 | publication date | 2007-05-26 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | The over-expression of p53 H179Y residue mutation causes the increase of cyclin A1 and Cdk4 expression in HELF cells | |
| P478 | volume | 304 |
| Q33274721 | A comparison of cell-cycle markers in skull base and sacral chordomas |
| Q47162757 | Actionable mutations in canine hemangiosarcoma. |
| Q47214159 | Differentially Expressed mRNA Targets of Differentially Expressed miRNAs Predict Changes in The TP53 Axis and Carcinogenesis Related Pathways in Human Keratinocytes Chronically Exposed to Arsenic. |
| Q37281446 | Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival |
Search more.